Form 4: NeuroMetrix CFO Thomas Higgins Reports Stock Transactions
SEC Form 4 Filing
Thomas Higgins, CFO of NeuroMetrix, Inc., reports the vesting of restricted stock units and subsequent transactions.
Summary
- On October 1, 2024, Thomas Higgins, the CFO of NeuroMetrix, Inc., reported transactions involving common stock.
- These transactions included the vesting of 469 restricted stock units at a price of $4.18 per share.
- Additionally, 48 shares were withheld for payment of withholding taxes at the same price.
- Following these transactions, Higgins directly owns 10,165 shares of NeuroMetrix common stock and 3,749 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock transactions, so the sentiment is neutral.
Industry Context
This is a standard SEC Form 4 filing, which is common for corporate insiders reporting changes in their beneficial ownership of company stock. It's a routine part of corporate governance and transparency.
Stakeholder Impact
- The transactions reported may have a minor impact on shareholders due to the change in ownership, but it's unlikely to be significant.
Key Dates
| Date | Description |
|---|---|
| November 22, 2023 | Date of grant of 5,625 restricted stock units. |
| January 1, 2024 | Start date for quarterly vesting of restricted stock units. |
| October 1, 2024 | Date of reported transactions: vesting of restricted stock units and withholding of shares for taxes. |
| October 2, 2024 | Date of signature for the Form 4 filing. |
Keywords
NeuroMetrix, NURO, Thomas Higgins, CFO, Form 4, Stock transaction, Restricted stock units, Vesting, Beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.